Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Thomas

Showing results (411-420 of 791) with videos related to

Pageof 80
Sort By:
Energy Technology (Weinheim, Germany)|February 1, 2021
Towards a Greener and Scalable Synthesis of Na<sub>2</sub>Ti<sub>6</sub>O<sub>13</sub> Nanorods and Their Application as Anodes in Batteries for Grid-Level Energy StorageDario M De Carolis, Dragoljub Vrankovic, Samira A Kiefer, et al.
The Lancet. Oncology|May 18, 2026
Real-world heart and lung doses from 30 000 National Health Service radiotherapy treatment plans in England: a national audit of breast radiotherapy practiceAnna M Kirby, Nathaniel Luke Hatton, Vibeke Nordmark Hansen, et al.
Cancer|January 26, 2011
Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trialAlexandra D Jensen, Marc W Münter, Helge G Bischoff, et al.
Anticancer Research|December 27, 2011
The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancerEsther Herpel, Katrin Jensen, Thomas Muley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2013
Comparison of total cortisol, free cortisol, and surrogate markers of free cortisol in diagnosis of adrenal insufficiency in patients with stable cirrhosisGiuseppe Fede, Luisa Spadaro, Tania Tomaselli, et al.
Respiratory Medicine|March 22, 2014
Characteristics of lung cancer after a previous malignancyNiels Reinmuth, Patrick Stumpf, Andreas Stumpf, et al.
Contraception|April 26, 2024
Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trialJeffrey T Jensen, Alison Edelman, Carolyn L Westhoff, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 16, 2023
Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remissionThomas Muley, Felix J Herth, Claus Peter Heussel, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 15, 2015
Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT studyChristos Sachpekidis, Christian Thieke, Vasileios Askoxylakis, et al.
Annals of Clinical Biochemistry|March 1, 2011
Point of care testing is appropriate for National Health Service health checkAnjly Jain, Jahm Want Persaud, Nandini Rao, et al.
Pageof 80

Showing results (411-420 of 791) with videos related to

Sort By:
Pageof 80
Energy Technology (Weinheim, Germany)|February 1, 2021
Towards a Greener and Scalable Synthesis of Na<sub>2</sub>Ti<sub>6</sub>O<sub>13</sub> Nanorods and Their Application as Anodes in Batteries for Grid-Level Energy StorageDario M De Carolis, Dragoljub Vrankovic, Samira A Kiefer, et al.
The Lancet. Oncology|May 18, 2026
Real-world heart and lung doses from 30 000 National Health Service radiotherapy treatment plans in England: a national audit of breast radiotherapy practiceAnna M Kirby, Nathaniel Luke Hatton, Vibeke Nordmark Hansen, et al.
Cancer|January 26, 2011
Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trialAlexandra D Jensen, Marc W Münter, Helge G Bischoff, et al.
Anticancer Research|December 27, 2011
The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancerEsther Herpel, Katrin Jensen, Thomas Muley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2013
Comparison of total cortisol, free cortisol, and surrogate markers of free cortisol in diagnosis of adrenal insufficiency in patients with stable cirrhosisGiuseppe Fede, Luisa Spadaro, Tania Tomaselli, et al.
Respiratory Medicine|March 22, 2014
Characteristics of lung cancer after a previous malignancyNiels Reinmuth, Patrick Stumpf, Andreas Stumpf, et al.
Contraception|April 26, 2024
Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trialJeffrey T Jensen, Alison Edelman, Carolyn L Westhoff, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 16, 2023
Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remissionThomas Muley, Felix J Herth, Claus Peter Heussel, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 15, 2015
Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT studyChristos Sachpekidis, Christian Thieke, Vasileios Askoxylakis, et al.
Annals of Clinical Biochemistry|March 1, 2011
Point of care testing is appropriate for National Health Service health checkAnjly Jain, Jahm Want Persaud, Nandini Rao, et al.
Pageof 80